Clinical Trial Update: NGS as the First-line Treatment in Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating next-generation sequencing-guided first-line treatment for advanced biliary tract cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Advanced Biliary Tract Cancer | Phase 2 | Status: COMPLETED